Patent details

Basic Information

Publication number:

LUC00352

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP221787369

Legal Status:

Pending & Published

Application number:

LUC00352

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/22/1703

Marketing Authorization Type:

Marketing Authorization Date:

12/12/2022

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

28/06/2024

First Marketing Authorization date:

12/12/2022

Grant date:

Activation date:

Publication date:

28/06/2024

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

12/12/2037

SPC Extension Expiration:

12/12/2037

Rejection date:

Withdrawal date:

Owner

From:

28/06/2024

 

 

Name:

NOVARTIS AG

Address:

Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Agent

Name:

Dennemeyer & Associates S.A.

From:

28/06/2024

Address:

55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)

To:

Publication

Bulletin

Bulletin Heading:

SPC1

Bulletin edition number:

2024/09

Publication date:

11/07/2024

Description:

Section C : Published requests for Supplementary Protection Certificates – I1 publication

Annual Fees

Annual Fee Due Date:

31/10/2034

Annual Fee Number:

21

Annual Fee Amount:

410 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
28/06/2024	Application Form	5
28/06/2024	Marketing authorization	3
28/06/2024	Outgoing Correspondence	1
28/06/2024	General Document	4
28/06/2024	Summary of the product caracteristics	41
28/06/2024	MA publication	16
28/06/2024	General Document	58
28/06/2024	Outgoing Correspondence	1
28/06/2024	Publication	1